“Operational and Governance Structure of Urology Groups,” Evan R. Goldfischer and Joel Young, Practice Management for Urology Groups, LUGPA’s Guidebook, First Edition, June 2017, pp. 1-18.

“Sexuality.” Kenneth Pollock, Evan Goldfischer, Alan Altman in: Blumenfield, M., and Strain, J. Psychosomatic Medicine, Lippincott Williams and Wilkins, Philadelphia, 2006, pp.631-670.

“Surgery: Percutaneous, Ureteroscopic Resection and Novel Approaches.” Evan R. Goldfischer and Glenn S. Gerber in: Hamdy, Basler, Neal, and Catalona: Urologic Malignancies, Churchill Livingstone, London, 2002, pp 372-378.

“Sexually Transmitted Infections.” Evan R. Goldfischer, Daniel S. Katz, and Ann Bollman in: Green- Hernandez, C., Singleton, J., and Aronzon, D.: Pediatric Primary Care, Lippincott, New York, 2001, pp 483-489.

Breul, Jurgen, Purcea, Daniela, Venetz, Werner, Cabri, Patrick, Dutailly, Pascale, Goldfischer, Evan. Efficacy of testosterone suppression with sustained release Triptorelin in advanced prostate cancer. Advances in Therapy (in press)

Kim, E., Deftel, A., Goldfischer, E.R., Baygani, S., Burns, P. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenifil. Current Medical Research and Opinion, 2014;2:1-11.

Seftel, A.D., Rosen, R.C., Hayes, R.P., Althof, S., Goldfischer, E., Shen, W., Sontag A. Effect of once daily tadalafil on confidence and perceived difficulty in performing sexual intercourse in men who were incomplete responders to as- needed PDE5 inhibitor treatment. International Journal of Clinical Practice. Volume 68 (7) 841-849, 2014.

Goldfischer, Evan R. Impact of Low Testosterone on Response to Treatment with Tadalafil 5 mg Once Daily for Erectile Dysfunction. Urology, Volume 83 (6) 1326-1333, 2014.

Kim, E., Seftel, A., Goldfischer, E.R., Ni, X., and Burns, P. A Return to Normal Erectile Function with Tadalafil Once Daily After an Incomplete Response to As-Needed PDE5 Inhibitor Therapy. Journal of Sexual Medicine published online July 10, 2013.

Goldfischer, Evan R., Sand, Peter, Thomas, Heather, Peters-Gee, Jill. Efficacy and Safety of Oxybutynin Topical Gel 3% in Patients with Urgency and/or Mixed Urinary Incontinence: A Randomized Double-Blind, Placebo-controlled Study. Neurourology and Urodynamics, Volume 34 (1) 2015, 37-43.

Clayton, A.H., Goldfischer, ER, Goldstein, I, DeRogatis, L., Nappi, Lewis-D’Agostino, DJ, Pyke, R., Kimura, T., Hebert, Pyke, R. Validity of the Decreased Sexual Desire Screener for Diagnosing Hypoactive Sexual Desire Disorder. J. Sex & Marital Therapy, Volume 39, (2) 2013, 132-143.

Goldfischer, E., Kowallczyk, J.J., Clark, W.R., Brady, E., Shane, M.A., Dgetluck, N., Klise, S.R. Hemodynamic Effects of Once-daily Tadalafil in Men with Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant alpha-Andregergic Antagonist Therapy: Results of a Multicenter Randomized, Double-Blind, Placebo-controlled Trial. Urology, Volume 79, (4) 875-882

Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R. Continued Efficacy and Safety of Flibanserin in Premenopausal Women with Hypoactive Sexual Desire Disorder (HSDD): Results from a Randomized Withdrawal Trial. J Sex Med. Volume 8, Number 11 (November 2011) 2011 pp 3160-72.

Donatucci, Craig, Brock, Gerald, Goldfischer, Evan R., Pommerville, Peter, Elion-Mboussa Albert, Kissel, Jay, Viktrup, Lars. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study. BJU International 2011: 107 (7) 1110-116.

Wyndaele, Jean-Jacques, Goldfischer, Evan, R. Morrow, Jon, Gong, Jason, Tseng, Li-Jung, Guan, Zhonghong, Choo, Myung-Soo. Patient-optimized doses of fesoterodine improve bladder symptoms in an open-label, flexible dose study. British Journal of Urology International (107) 603-611, 2010.

Creating lasting memories on a family trip to Kenya, Tanzania, and Zanzibar. Evan R. Goldfischer. International Travel News. January 2011, pp 20-26.

Kaplan, Steven, Goldfischer, Evan, R., Steers, William, Gittleman, Marc, Andoh, Masakazu, Forero- Schwanhaeser, Sergio. Solifenacin treatment in men with overactive bladder: effects on symptoms and patient reported outcomes. The Aging Male. June 2010, 13:100-107, 2010.

Stroberg, Peter, Kaminetsky, Jed, Park, Nam Cheol, Goldfischer, Evan R., Creanga, Dana, Stecher, Vera. Hardness, function, emotional well-being, satisfaction and the overall sexual experience in men using 100mg fixed dose or flexible dose sildenafil citrate International Journal of Impotence Research July 22 (4), 284-289, 2010.

Wyndaele, Jean-Jacques, Goldfischer, Evan, R. Morrow, Jon, Gong, Jason, Tseng, Li-Jung, Guan, Zhonghong, Choo, Myung-Soo. Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study. The International Journal of Clinical Practice. 63:560-567, 2009.

Clayton, A.H., Goldfischer, E.R., Goldstein, I., Derogatis, L., Lewis-D’Agostino, D.J., Pyke, R. Validation of the Decreased Sexual Desire Screener (DSDS): A Brief Diagnostic Instrument for Generalized Acquired Female Hypoactive Sexual Desire Disorder (HSDD). Journal of Sexual Medicine 6:3 pp730-738, 2009.

McCullough, Andrew R., Steidle, Christopher P., Kaufmann, Joel, Goldfischer, Evan R., Klee, Brian, Carlsson, Martin. Sildenifil Citrate Efficacy 8 hours postdose in men with mild to moderate erectile dysfunction. International Journal of Impotence Research. 20: 388-395, 2008.

McCullough, Andrew R., Steidle, Christopher P., Kaufmann, Joel, Goldfischer, Evan R., Klee, Brian, Carlsson, Martin. Efficacy of Sildenafil 100mg for 8 Hours: Results of 2 Randomized, Double-Blind Trials in Men with Mild to Moderate Erectile Dysfunction. Submitted.

Sharlip, I.D., Shumaker, B.P., Hakim, L.S., Goldfischer, E.R., Natanegara, F., Wong, D.C. Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Obervatuions in men with ED in the National Tadalafil Study in the United States (MOMENTUS). Journal of Sexual Medicine, 2008;5:716-725.

Parks, Joan, Goldfischer, Evan R., and Coe, Fredric. Changes in urine volume accomplished by physicians treating nephrolithiasis. J. Urology 169: 863-870, 2003.

Parks, Joan, Goldfischer, Evan R., Asplin, John, and Coe, Fredric. A single 24-hour urine collection is inadequate for medical evaluation of nephrolithiasis. J. Urology 167: 1607-1612, 2002.

Goldfischer, Evan, and Turner, Craig. Partial renal infarction secondary to thromboembolus. Infections in Urology 12: 109-112, 1999.

Jabbour, M.E., Goldfischer, E.R., Anderson, A.E., Kushner, L., and Smith, A.D. Failed endopyelotomy: Low expression of TGF-B regardless of the presence or absence of crossing vessels. Journal of Endourology 13: 295-298, 1999.

Goldfischer, Evan, Stravodimos, Konstantinos, Jabbour, Michel, Klima, Wlodzimierz, Anderson, Ann, and Smith, Arthur. Acute Ureteral elongation in two animal models using a balloon expander. Journal of Endourology 13: 273-278, 1999.

Kirsch, E., Straus, F., Goldfischer, E.R., Steinberg, G., and Gerber, G. Benign adenomatous multicystic kidney tumor (Perlmann’s Tumor) and renal cortical carcinoma with adenomatous multicystic features: 12 cases. Urology 53: 65-70, 1999.

Hom, D., Eiley, D., Lummerman, J., Siegel, S., Goldfischer, E.R., and Smith, A.D. Complete renal embolization as an alternative to nephrectomy. J. Urology 161: 24-27, 1999.

Jabbour, M.E., Goldfischer, E.R., Anderson, A.E., Smith, A.D., and Kushner, L. Endopyelotomy failure is associated with reduced transforming growth factor-B. J. Urology 160: 1991-1994, 1998.

Stravodimos, Konstantinos, Anderson, Ann, Goldfischer, Evan, R., Jabbour, Michel, Klima, Wlodzimierz, Jabbour, Michel, and Smith, Arthur. Necrosis of the urethra and tissue sloughing: a delayed complication following transurethral microwave thermotherapy. Journal of Endourology 12: 379-380, 1998.

Goldfischer, Evan, R., Stravodimos, Konstantinos, Jabbour, Michel, Klima, Wlodzimierz, and Smith, Arthur. Percutaneous removal of a stone from a caliceal diverticulum in a patient with nephroptosis. Journal of Endourology 12: 365-366, 1998.

Sahin, Ahmet, Eiley, David, Goldfischer, Evan, R., Stravodimos, Kostantinos, Zeren, Sinan, Isenberg, Henry, and Smith, Arthur. The in vitro bactericidal effect of microwave energy on bacteria that cause prostatitis Urology 52: 411-416, 1998.

Jabbour, Michel, Goldfischer, Evan, R., Klima, Wlodzimierz, Stravodimos, Kostantinos, and Smith, Arthur. Endopyelotomy for Horseshoe kidneys and congenital renal anomalies. J. Urology 160: 694- 697, 1998.

Jabbour, Michel, Goldfischer, Evan, R., Klima, Wlodzimierz, Stravodimos, Kostantinos, and Smith, Arthur. Endopyelotomy after failed pyeloplasty: The long term results. J. Urology 160: 690-693, 1998.

Goldfischer, Evan, R., Jabbour, Michel, Stravodimos, Kostantinos, Klima, Wlodzimierz, and Smith, Arthur. Techniques of Endopyelotomy. British Journal of Urology 82: 1-7, 1998.

Goldfischer, Evan, R., and Smith, Arthur. 1998 AUA take home messages on endourology and laparoscopy. AUA Today 3: 18-19, 1998.

Stravodimos, Konstantinos, Goldfischer, Evan, R., Smith, Arthur. Endourological treatment for ureteropelvic junction obstruction. Advantages and disadvantages. Hellenic Urology 10: 36-40, 1998.

Stravodimos, Konstantinos, Goldfischer, Evan, R., Klima, Wlodzimierz, Jabbour, Michel, and Smith, Arthur. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: a single institution experience. Urology 51: 1008-1012, 1998.

Goldfischer, Evan, R., and Smith, Arthur. Endopyelotomy revisited. Urology 51: 855-858, 1998.

Gerber, Glenn, Gornik, Heather, Goldfischer, Evan, R., Chodak, Gerald, and Rukstalis, Daniel. Evaluation of changes in Prostate specific antigen in men with clinically localized prostate cancer managed without initial therapy. J. Urology 159: 1243-1246, 1998.

Goldfischer, Evan, R., Eiley, David, and Smith, Arthur. Novel hemostatic nephrostomy tube. J. Endourology 11: 405-407, 1997.

Goldfischer, Evan, R., Cromie, William, J. Bilateral Suprarenal Cryptorchidism in a patient with Pfeiffer syndrome. J. Urology 158: 597-598, 1997.

Gerber, Glenn, S., Goldfischer, Evan, R., and Bales, Greg, T. Serum creatinine measurements in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 49: 697- 702, 1997.

Goldfischer, Evan. R., Cromie, William, J. Omphalopagus twins with covered cloacal extrophy. J. Urology 157: 1004-1005, 1997.

Goldfischer, Evan. R., Gerber, Glenn, S. Endoscopic management of ureteral strictures. J. Urology 157: 770-775, 1997.

Goldfischer, Evan. R., Cromie, William, J., Karrison, Ted, G., Naszkiewitz, Lela, and Gerber, Glenn, S. A randomized, prospective, double-blind study of the effects on pain perception of lidocaine jelly versus plain lubricant during outpatient rigid cystoscopy. J. Urology 157: 90-94, 1997.

Cromie, William, J., Goldfischer, Evan, R., and Kim, Jae. Laparoscopic creation of a continent cecal tube for anterograde colonic irrigation. Urology 47: 905-907, 1996.

Goldfischer, Evan, A Special Opportunity to Visit the Orangutans of Borneo with The Woman Who Knows Them Best. International Travel News, December 2017, Volume 42. Number 10.

Wassim Abida, Josep Maria Piulats, Ray McDermott, David Morris, Jeremy Shapiro, Evan R. Goldfischer, Nicholas Vogelzang, Arif Hussain, Akash Patnaik, Peter Ostler, Alejo Rodriguez-Vida, Elias Pintus, Jose Angel Arranz Arija, Srikala Sridhar, Gedske Daugaard, Florence Joly, Laurence Krieger, Brieuc Sautois, Simon Watkins, Andy Simmons, Jowell Go, Melanie Collins, Tony Golsorkhi, Charles Ryan, Howard Scher, Simon Chowdhury. The TRITON Clinical Trial Program: Evaluation of the Poly (ADP-Ribose) Polymerase (PARP) Inhibitor Rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD). Presented at the 28th International Prostate Cancer Update January 2018, Beaver Creek, Colorado.

Yair Lotan, Jay Raman, Shahrokh Shariat, Laimonis Kavalieris, Chris Frampton, Christchurch, Henry Crist, Elsie Jacobson, Jimmie Suttie, David Darling, Scott Asroff, Doug Scherr, George Adams, Evan Goldfischer, Jeffrey Thill, Joseph Williams, Joshua Stein, CT, Paul O’Sullivan. 745: The Development and Clinical Validation of a High Sensitivity Urine biomarker test for the Determination of Recurrence in Urothelial Carcinoma Patients (late breaking abstract presented at 2016 AUA annual meeting in San Diego)

Chamie, Karim, Schoenberg, Mark, Wolk, Fredrick, Barkoukis, Michael, Goldfischer, Evan, DeCillis, Arthur, Lamm, Donald. An open-label, multicenter, phase 3 study evaluating the efficacy and tolerability of oportuzumab monatox (OM) in subjects with non-muscle-invasive carcinoma in situ (CIS) and/or high-grade papillary disease of the bladder previously treated with bacillus Calmette-Guerin. (late breaking abstract presented at 2016 AUA annual meeting in San Diego)

Goldfischer, E.R. Lance, R., Berge, L, Pappadakis, J and Spiegel, K. Prostate Cancer (APCA) with Androgen Deprivation Therapy (ADT) Across Large Urology Group Practices. Presented at Northeaster AUA sectional meeting, Amelia Island, Florida, November 2014.

Goldfischer, E.R., Kim, E. Seftel, A., Baygani, S., and Burns, P. Does testosterone level influence men’s response to tadalafil once daily for the treatment of erectile dysfunction (ED)? Presented SMSNA 2013.

Kim, E., Seftel, A., Goldfischer, E.R., Baygani, S., and Burns, P. Efficacy of prn PDE5 inhibitor therapy vs. tadalafil once-daily on improvement in erectile dysfunction. Presented SMSNA 2013.

Goldfischer, E., Sand, P., Peters-Gee J. Efficacy and safety of oxybutynin topical gel (84 mg or 56 mg/day) in patients with urgency and/or mixed urinary incontinence: Results of a randomized, double-blind, placebo-controlled study. The Journal of Urology. 187: Issue 4 Supplement, e214-e215, 2012.

Seftel, A. Kim, E. Goldfischer, E. Effect of once-daily tadalafil on confidence in performing sexual intercourse and difficulty in performing sexual intercourse for men with erectile dysfunction, who were incomplete responders to as-needed PDE-5 inhibitor treatment. Presented at the European Society of Sexual Medicine, Amsterdam, TBD.

Kim, E., Seftel, A., and Goldfischer, Evan. “Tadalafil Once Daily Following PRN Phosphodiesterase Type 5 Inhibitor Treatment, An Assessment of return To Normal Erectile Function. Presented at the World Meeting on Sexual Medicine, Chicago, IL, August 26-30, 2012.

Goldfischer, E., Sand, P., Peters-Gee J. Efficacy and safety of oxybutynin topical gel (84 mg or 56 mg/day) in patients with urgency and/or mixed urinary incontinence: Results of a randomized, double-blind, placebo-controlled study. The Journal of Urology. 187: Issue 4 Supplement, e214-e215, 2012.

Seftel, A. Kim, E. Goldfischer, E. Effect of once-daily tadalafil on confidence in performing sexual intercourse and difficulty in performing sexual intercourse for men with erectile dysfunction, who were incomplete responders to as-needed PDE-5 inhibitor treatment. Presented at the European Society of Sexual Medicine, Amsterdam, TBD.

Kim, E., Seftel, A., and Goldfischer, Evan. “Tadalafil Once Daily Following PRN Phosphodiesterase Type 5 Inhibitor Treatment, An Assessment of return To Normal Erectile Function. Presented at the World Meeting on Sexual Medicine, Chicago, IL, August 26-30, 2012.

Goldfischer, Evan, Sand, Peter, Peters-Gee, Jill. Efficacy and Safety of Oxybutynin Topical Gel (84mg or 56mg) in Patients with Urgency and/or Mixed Incontinence: Results of a Randomized, Double-Blind Placebo Controlled Study. Journal of Urology Volume 187: 4, supplement pp e214-215. Presented at a Podium Session of the 2012 AUA Annual Meeting.

Staskin, David, Goldfischer, Evan, Bidair, Mohamed, and Dave, Kaushik. A Once Daily Titratable Gel Formulation for Transdermal Oxybutynin Delivery for the Treatment of OAB. Presented at the AUA north Central sectional Meeting, Palm Desert, California, October 2011.

Seftel, A., Goldfischer, E., Kim, E. Zeigler, H., Burns, P. Tadalafil Once Daily: Onset of Efficacy. Journal of Sexual Medicine December 2009: Volume 6 Issue s5, Special Issue: Proceedings of the 12th Annual Meeting of the European Society for Sexual Medicine. Lyon, France November 15-18, 2009.

Morrow, J.D., Goldfischer, E.R., Gong, J., Tseng, L., Guan, Z., Wyndaele, J. Efficacy and Tolerability of Fesoterodine in Subjects Stratified by Dose Escalation Status: Results of an Open-Label Flexible-Dose Study. 2009 International Continence Society – 39th Annual Meeting: September 29-October 3, 2009. Published as a read by title online at www.ics.org.

Hellstrom WJG, Marks LS, Swerdloff R, Wang C, Kaufman JM, Goldfischer E.R., Miner MM, Shabsigh R. Effects of long-acting testosterone undecanoate intramuscular injection on prostate health outcomes in hypogonadal men. Abstract presented at: American Society of Andrology 34th Annual Meeting; April 4-7, 2009; Philadelphia, PA.

Hellstrom WJG, Marks LS, Swerdloff R, Wang C, Kaufman JM, Goldfischer E.R., Miner MM, Shabsigh R. Impact of long-acting testosterone undecanoate intramuscular injection on sex hormones in hypogonadal men. Abstract presented at: American Society of Andrology 34th Annual Meeting; April 4-7, 2009; Philadelphia, PA.

Hellstrom WJG, Marks LS, Swerdloff R, Wang C, Kaufman JM, Goldfischer E.R., Miner MM, Shabsigh R. Improved depression-related outcomes in men treated with a novel long-acting testosterone undecanoate intramuscular injection. Abstract presented at Southeastern Section of the AUA 73rd Annual Meeting; March 26-29, 2009; Mobile, AL.

Goldfischer, E.R., Breaux, Katz, M., Kaufman, J., Smith, W.B., Patel, P., Mikl, J., Sand, M., and Pyke, R. Safety and tolerability of continued flibanserin treatment in premenopausal women with hypoactive sexual desire disorder: results from the ROSE study. Journal of Sexual Medicine December 2008:70. Presented at the ESSM/ISSM meeting December 8, 2008 in Brussels.

Goldfischer, E.R., Breaux, Katz, M., Kaufman, J., Smith, W.B., Patel, P., Mikl, J., Sand, M., and Pyke, R. Efficacy of continued flibanserin treatment in premenopausal women with hypoactive sexual desire disorder: results from the ROSE study. Journal of Sexual Medicine December 2008:1. Presented at the ESSM/ISSM meeting December 8, 2008 in Brussels.

Goldfischer, Evan, R., Clayton, Anita, Goldstein, Irwin, Lewis-D’agostini, Diane, and Pyke, Robert. Decreased sexual desire screener (DSDS) for diagnosis of hypoactive sexual desire disorder in women. Presented at the sexual Medicine Society of North America Meeting October 17, 2008, Toronto Canada.

Goldfischer, E.R., Breaux, J., Katz, M., Kauffman, J., Smith, W.B., Patel, P., Mikli, J., Sand, M., and Pyke, R. Efficacy and Safety of flibanserin in premenopausal women with hypoactive sexual desire disorder: results from the randomized withdrawal ROSE study. Presented at the sexual Medicine Society of North America Meeting October 17, 2008, Toronto Canada.

Goldfischer, E., Wyndaele, J.J., Morrow, J.D., Gong, J., Tseng, L.J. Effects of Fesoterodine on symptom relief and patient satisfaction in subjects with overactive bladder. Journal of Pelvic Medicine and Surgery 14:325, 2008. Presented at the American Urogynecological Society, September 4, 2008, Chicago, Illinois.

Kaufman, Joel, McCullough, Andrew, Steidle, Christopher, Goldfischer, Evan, Klee, Brian, Carlsson, Martin. Erectile function and erection hardness at intercourse attempts 8 hours postdose in men with mild to moderate erectile dysfunction receiving sildenafil citrate 100mg. Journal of Urology. Suppl., vol 179, p 428. Presented at the AUA 2008 annual meeting.

Goldfischer, E., Pyke, R., Mikel, J., The ROSE study: Placebo controlled randomized withdrawal trial of flibanserin for hypoactive sexual desire disorder in premenopausal women (presented at the Ninth Congress of the European Federation of Sexology, Rome April 16, 2008).

Pyke, Robert, Goldfischer, Evan, Miki, Jaromir. Safety and tolerability of Flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): Results from the ROSE study. Presented at the American Psychiatric association, annual meeting, Washington D.D. May 6, 2008.

Goldfischer, ER, Clayton, AH, Goldstein, I, Lewis-D’Agostino, DJ, Pyke, R. Decreased Sexual Desire Screener (DSDS) for diagnosis of hypoactive sexual disorder in women. Obstetrics and Gynecology vol 111, 4(suppl) April 2008, p 109S. Presented at the American College of Obstetrics and Gynecology, New Orleans May 6, 2008.

Goldfischer, Evan, Cotton, Dan, Miki, Jaromir, Pyke, Robert, Sand, Michael. Efficacy of continued flibanserin treatment on sexual functioning in premenopausal women with HSDD: Results from the ROSE study. Presented at the ISSWSH meeting, San Diego, February 22, 2008.

Goldfischer, Evan, Cotton, Dan, Miki, Jaromir, Pyke, Robert, Sand, Michael. Efficacy of continued flibanserin treatment on sexual desire and satisfying sexual events in premenopausal women with HSDD: Results from the ROSE study. Presented at the ISSWSH meeting, San Diego, February 22, 2008.

Pyke, Robert, Goldfischer, Evan R., Mikl, Jaromir. Randomized withdrawal trial of flibanserin for hypoactive sexual desire disorder. Presented at the 59th Institute on Psychiatric Services of the American Psychiatric Association, Poster 77, Bulletin, page 69, New Orleans, LA October 12, 2007.

Steidle, C., McCullough, A., Kaufman, J., Goldfischer, E., Klee, B., and Tseng, L. Efficacy of Sildenifil Citrate 100mg for 8 hours: double-blind placebo-controlled trials in mild to moderate erectile dysfunction. Journal of Sexual Medicine 2008; 5 (suppl 1):27 Presented at the Sexual Medicine Society of North America Annual Meeting, Chicago, Illinois, December 7, 2007.

Goldfischer, Evan, Pyke, Robert, Mikle, Jaromir. The Rose Study: Placebo-controlled randomized withdrawal trial of flibanserin for hypoactive sexual desire disorder in pre- menopausal women. Journal of Sexual Medicine 2008; 5 (suppl 1):34 Presented at the Sexual Medicine Society of North America Annual Meeting, Chicago, Illinois, December 7, 2007.

McCullough, Andrew, Steidle, Christopher, Kaufman, Joel, Goldfischer, Evan, Klee, Brian, Carlsson, Martin. Efficacy outcomes for sexual intercourse attempts 8 hours after Administration of Sildenafil 100mg in treatment responders. Journal of Sexual Medicine 2008; 5 (suppl 1):30. Presented at the Sexual Medicine Society of North America Annual Meeting, Chicago, Illinois, December 7, 2007.

Goldfischer, Evan, Steidle, Christopher, McCullough, Andrew, Kaufman, Joel, Klee, Brian, Carlsson, Martin. Tolerability of fixed-dose Sildenafil 100mg in erectile dysfunction. Journal of Sexual Medicine 2008; 5 (suppl 1):28. Presented at the Sexual Medicine Society of North America Annual Meeting, Chicago, Illinois, December 7, 2007.

Kaufman, Joel, McCullough, Andrew, Steidle, Christopher, Goldfischer, Evan, Klee, Brian, Carlsson, Martin. 8 hours post-dose, Sildenafil citrate 100mg increased the proportion of successful intercourse attempts and of completely hard erections. Journal of Sexual Medicine 2008; 5 (suppl 1):28 Presented at the Sexual Medicine Society of North America Annual Meeting, Chicago, IL, December 7, 2007.

Steidle, Christopher, McCullough, Andrew, Kaufman, Joel, Goldfischer, Evan, Klee, Brian, Carlsson, Martin. 8 hours post-dose, Sildenafil citrate 100mg improved erectile function. Journal of Sexual Medicine 2008; 5 (suppl 1):28. Presented at the Sexual Medicine Society of North America Annual Meeting, Chicago, Illinois, December 7, 2007.

Goldfischer, Evan, Pollock, Kenneth, McNary, Scot, Kaminetsky, Jed. A randomized double-blind, placebo-controlled study to evaluate the efficacy of Sildenafil in homosexual men with erectile dysfunction (ED). Journal of Sexual Medicine 2008; 5 (suppl 1):26 Presented at the Sexual Medicine Society of North America Annual Meeting, Chicago, Illinois, December 7, 2007.

Sharlip, Ira D., Shumaker, Bryan P., Hakim, Lawrence S., Goldfischer, Evan, Natanegara, Fanni and Wong, David G. Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States (MOMENTUS). Journal of Sexual Medicine, in press.

Goldfischer, Evan R., Clayton, Anita, Goldstein, Irwin, Pyke, Robert, Lewis- D’Agostino, Diane. Validation of the decreased sexual desire screener (DSDS): A brief diagnostic instrument for generalized, acquired hypoactive sexual desire disorder in women. Presented at the 2007 American Psychiatric Association Meeting, new research abstracts NR710, Page 305.

Onel, E., Lewis-Dagostino, D., Pyke, R., DeRogatis, A.H., Goldfischer, E.R., Goldstein, I. Validation of the decreased sexual desire screener (DSDS): A brief diagnostic instrument for generalized, acquired hypoactive sexual desire disorder in women. Fertility and Sterility Vol 86, suppl 2. September 2006, p 529. Presented at the 62nd annual meeting of the American Society for Reproductive Medicine.

Goldfischer, Evan R., “Speak out” Urology Times October 1, 2006, p.29.

Kaplan, Steve, Gittelman, Marc, Goldfischer, Evan R., Forero-Schwanhaeser, Sergio. Improvement in patient-reported outcomes for two cohorts of men treated with solifenacin for overactive bladder. European Urology 2007. Presented at the European Association of Urology, Berlin 2007.

Goldfischer, Evan, R., Glasser, Dale, Carlsson, Martin. The tolerability of tolterodine is not diminished in older patients: an analysis of 5 randomized, double-blind, placebo-controlled trials. The Canadian Journal of Urology 13(4), p3224. Presented at the 2006 AUA Northeastern Section meeting. Goldfischer, Evan R., McVary, Kevin, Tseng, Li-Jung, van den Ende, Gene. Sildenifil Citrate (Viagra) is efficacious and well tolerated in men with both erectile dysfunction and Lower Urinary tract symptoms. The Canadian Journal of Urology 13(4), p3222. Presented at the 2006 AUA Northeastern Section meeting.

Sharlip, IShumaker, B., Hakim, L., Goldfischer, E., Garcia, C., Natanegara, F., and Wong, D. Tadalafil is efficacious for the treatment of erectile dysfunction in men over 65 years of age: Results from Momentus (multiple observations in men with ED in national Tadalafil study in the US. Journal of Sexual Medicine 2006; 3 (suppl 1) 59. Presented at the 2005 Sexual Medicine Society of North America Fall Meeting.

Goldfischer, Evan, R., Guan, Zhonghong, and Wang, Joseph. Efficacy and tolerability of Tolterodine Extended Release in continent patients with overactive bladder and nocturia. The Canadian Journal of Urology 12(4), p2789. Presented at the 2005 AUA Northeastern/New England Section meeting.

Preminger, G., Lingeman, J., Goldfischer, E., Monga, M., Auge, B., Pietrow, P., Assimos, D., Norman, R., Dushinski, J., Macaluso, J., Hoenig, D., Kahnoski, R., and Landman, J. A. Prospective randomized clinical trial comparing levels of symptoms and discomfort associated with two investigational and two currently marketed ureteral stents. J. Urology 173, suppl 1, A-1683, 2005. Presented at the 2005 AUA meeting.

Goldfischer, Evan, R., Eardley, Ian, and Segerson, Thomas. Vardenifil improves erectile function in men with significant comorbidities associated with erectile dysfunction (ED) J. Urology 167, suppl: 714, 2002.

Goldfischer, E., Park, J.H., Hurlburt, J., Asplin, J.R., and Coe, F. One urine is inadequate for the medical evaluation of nephrolithiasis. J Endourology 15, suppl 1: A-6, 2001. Presented at the 2001 World Congress of Endourology.

Goldfischer, Evan, Katz, Daniel, Libin, Mark, and Solliday, Michael. The Clear Sheath: Improving visualization during percutaneous stone extraction. J Endourology 14, suppl 1: A-113, 2000. Presented at the 2000 World Congress of Endourology. Goldfischer, Evan, Katz, Daniel, Libin, Mark, and Salevitz, Bernard. Is there value in completing an endourology fellowship if you are pursuing a career in private practice? J Endourology 13, suppl 1: A- 15, 1999. Presented at the 1999 World Congress of Endourology.

Al-Kandari, ahmed, Bernardo, Norberto, Stravodimos, Konstantinos, Goldfischer, Evan, Jabbour, Michel, Gotesman, Alexander, Pinkhasov, David, Dinlenc, Caner, Anderson, Ann, and Smith, Arthur. Assessing the degree of renal trauma secondary to Amplatz sequential fascial (ASF) dilators versus balloon dilation during percutaneous renal surgery in an animal model. J Endourology 13, suppl 1: A- 15, 1999. Presented at the 1999 World Congress of Endourology.

Stravodimos, Konstantinos, Al-Kandari, Ahmed, Goldfischer, Evan, Jabbour, Michel, Bernardo, Norberto, Klima, Wlodzimierz, Anderson, Ann, and Smith, Arthur. Acute ureteral elongation using a tissue expander in two animal models. J Urology 161: 11, 1999. Presented at the 1999 AUA Annual Meeting.

Goldfischer, Evan, Al-Kandari, Ahmed, Bernardo, Norberto, Jabbour, Michel, Stravodimos, Kostantinos, Klima, Wlodzimierz, and Smith, Arthur. Percutaneous surgery in the hypermobile kidney. J Urology 161: V49, 1999. Presented at the 1999 AUA Annual Meeting.

Jabbour, Michel, Al-Kandari, Ahmed, Goldfischer, Evan, Stravodimos, Konstantinos, Klima, Wlodzimierz, Tillem, Steve, Bernardo, Norberto, Badlani, Gopal, and Smith, Arthur. Endourological techniques of the lower urinary tract. J Urology 161: V41, 1999. Presented at the 1999 AUA Annual Meeting.

Goldfischer, Evan, Stravodimos, Kostantinos, Jabbour, Michel, Klima, Wlodzimierz, and Smith, Arthur. Percutaneous surgery in the hypermobile kidney. J Endourology 12: S202, S247. Presented at the 1998 World Congress on Endourology and SWL.

Jabbour, Michel, Goldfischer, Evan, Anderson, Ann, Kushner, Leslie, and Smith, Arthur. TGFB in failed endopyelotomy: a low expression with or without crossing vessels. J Endourology 12: S102. Presented at the 1998 World Congress on Endourology and SWL.

Jabbour, Michel, Goldfischer, Evan, Stravodimos, Konstantinos, Klima, Wlodzimierz, Al-Kandari, Amed, and Smith, Arthur. Endopyelotomy in congenital renal anomalies. J Endourology 12: S129. Presented at the 1998 World Congress on Endourology and SWL.

Jabbour, Michel, Goldfischer, Evan, Stravodimos, Konstantinos, Klima, Wlodzimierz, Al-Kandari, Amed, and Smith, Arthur. The long term outcome of endopyelotomy on patients with failed pyeloplasty. J Endourology 12: S118. Presented at the 1998 World Congress on Endourology and SWL

Jabbour, Michel, Goldfischer, Evan, Stravodimos, Konstantinos, Klima, Wlodzimierz, Tillem, Steve, Badlani, Gopal, and Smith, Arthur. Endourology of the lower urinary tract. J Endourology 12: S243. Presented at the 1998 World Congress on Endourology and SWL.

Stravodimos, Konstantinos, Goldfischer, Evan, Jabbour, Michel, Klima, Wlodzimierz, Al-Kandari, Ahmed, and Smith, Arthur. The LIJ experience on transurethral microwave thermotherapy. J Endourology 12: S210. Presented at the 1998 World Congress on Endourology and SWL.

Stravodimos, Konstantinos, Goldfischer, Evan, Sahin, Ahmet, Eiley, David, Zeren, Sinan, Jabbour, Michel, Klima, Wlodzimierz, Isenberg, Henry, and Smith, Arthur. Microwave energy: is there a role for bacterial prostatitis? J Endourology 12: S230. Presented at the 1998 World Congress on Endourology and SWL.

Stravodimos, Konstantinos, Goldfischer, Evan, Jabbour, Michel, Klima, Wlodzimierz, Al-Kandari, Ahmed, Anderson, Ann, and Smith, Arthur. Acute elongation of the ureter using a Tissue expander. J Endourology 12: S82. Presented at the 1998 World Congress on Endourology and SWL. Awarded Third Prize in Endourological Society Essay Contest.

Jabbour, Michel, Goldfischer, Evan, Anderson, Ann, Kushner, Leslie, and Smith, Arthur. Failed endopyelotomy is associated with reduced levels of TGFB. J Urology 159: 52A, 1998. Presented at the 1998 AUA annual meeting.

Sahin, Ahmet, Stravodimos, Konstantinos, Goldfischer, Evan, Smith, Arthur, and Singhal, Pravin. Esherichia Coli promotes macrophage apoptosis: a new marker of virulence. J Urology 159: 1055A, 1998. Presented at the 1998 AUA annual meeting.

Goldfischer, Evan, Jabbour, Michel, Klima, Wlodzimierz, Stravodimos, Konstantinos, and Smith, Arthur. Endopyelotomy after failed pyeloplasty: Initial assessment and long-term results. J Urology 159: 215A, 1998. Presented at the 1998 AUA annual meeting.

Zeren, Sinan, Eiley, David, Sahin, Ahmet, Goldfischer, Evan, Smith, Arthur. Percutaneous resection of renal transitional cell carcinoma: long-term outcome for 42 patients. Br J. Urol. 80: Suppl. 2, 47, 1997.

Lee, Chi, Eiley, David, Goldfischer, Evan, and Franco, Israel. Laparoscopic nephrectomy for the dysplastic pelvic kidney. J. Endourology 11: S76, 1997. Presented at the 1997 World Congress on Endourology and SWL.

Press, Scott, Eiley, David, Goldfischer, Evan, Zeren, Sinan, and Smith, Arthur. Heparinization following percutaneous renal surgery: what is the risk for massive hemorrhage? J. Endourology 11: S143, 1997. Presented at the 1997 World Congress on Endourology and SWL.

Lumerman, Jeff, Hom, David Eiley, David, Goldfischer, Evan, and Smith, Arthur. The dilemma involved in diagnosing partial renal infarction. J. Endourology 11: S192, 1997. Presented at the 1997 World Congress on Endourology and SWL.

Eiley, David, Goldfischer, Evan, Zeren, Sinan, Oszvath, Bob, and Smith, Arthur. Nephrostomy tracts through angiomyolipomas: to bleed or not to bleed? J. Endourology 11: S143, 1997. Presented at the 1997 World Congress on Endourology and SWL.

Hettiarachchi, Janaka, Eiley, David, Sahin, Ahmet, Goldfischer, Evan, and Smith, Arthur. The effects of gas sterilization on glidewire properties. J. Endourology 11: S142, 1997. Presented at the 1997 World Congress on Endourology and SWL.

Eiley, David, Gupta, Mantu, Ikeguchi, Edward, Goldfischer, Evan, and Smith, Arthur. Treatment options for renal peri-hilar cysts. J. Endourology 11: S125, 1997. Presented at the 1997 World Congress on Endourology and SWL.

Eiley, David, Hom, David, Lumerman, Jeff, Goldfischer, Evan, Siegal, David, and Smith, Arthur. Complete renal angioinfarction, an alternative to simple nephrectomy. J. Endourology 11: S129, 1997. Presented at the 1997 World Congress on Endourology and SWL.

Zeren, Sinan, Eiley, David, Sahin, Ahmet, Goldfischer, Evan, and Smith, Arthur. Percutaneous resection intrarenal tumors: the LIJ experience. J. Endourology 11: S87, 1997. Presented at the 1997 World Congress on Endourology and SWL.

Eiley, David, Goldfischer, Evan, Sahin, Ahmet, Zeren, Sinan, and Smith, Arthur. The safety urethral guidewire – a useful adjunct to transurethral surgery. J. Endourology 11: S114, 1997. Presented at the 1997 World Congress on Endourology and SWL.

Eiley, David, Sahin, Ahmet, Zeren, Sinan, Goldfischer, Evan, and Smith, Arthur. The effects of TUMT on E. coli in vitro. J. Endourology 11: S56, 1997. Presented at the 1997 World Congress on Endourology and SWL.

Sahin, Ahmet, Singhal, Pravin, Eiley, David, Goldfischer, Evan, and Smith, Arthur. E.coli- uroepithelial cell interaction products modulate kidney fibroblast proliferation. J. Endourology 11: S152, 1997. Presented at the 1997 World Congress on Endourology and SWL.

Goldfischer, Evan R., Kim, Jae, H., and Cromie, William, J. Surgical creation of a continent cecal tube for anterograde colonic irrigation. J. Urology 155: 307A, 1996. Presented at the 1996 AUA Annual Meeting.

Gornick, Heather, L., Goldfischer, Evan, R., Gerber, Glenn, S., and Rukstalis, Daniel, B. Evaluation of PSA velocity in men with localized prostate cancer treated with conservative therapy. J. Urology 153: 353A, 1995.

Goldfischer, Evan. R., Gornik, Heather, L., Rukstalis, Daniel, B., and Chodak, Gerald, W. Evaluation of the toxicity and effects on PSA velocity of 4-HPR in men with localized prostate cancer. American Society of Clinical Oncology. 14: 241, 1995. Presented at 1995 American Society of Clinical Oncology Annual Meeting.

Goldfischer, Evan. R., Rinker-Schaeffer, Carrie, W. Rukstalis, Daniel, B. and Stadler, Walter, J. Loss of heterozygosity on the 9P chromosomal arm in testicular cancer. J. Urology 153: 311A, 1995. Presented at the 1995 AUA Annual Meeting.

Goldfischer, Evan, R., Gornik, Heather, L., Rukstalis, Daniel, B. Gerber, Glenn, S., and Chodak, Gerald, W. The tolerability and effects on PSA of fenretinide in men with localized prostate cancer. J. Urology 153: 382A, 1995. Presented at 1995 AUA Annual Meeting.